Drug intelligence / Profile preview

bufei huoxue capsules

Development stage
Unknown
Lead developer
Guangdong Leiyun Shang Pharmaceutical
Administration
Oral
01

Overview

Bufei Huoxue Capsules is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Changshu Leiyunshang Pharmaceutical. It is an NMPA-approved pharmaceutical product in China, primarily indicated for the treatment of chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD) and chronic bronchitis, particularly in patients exhibiting Qi deficiency and blood stasis. The formulation is composed of three key botanical ingredients: *Astragalus membranaceus* (Huangqi), *Paeonia lactiflora* (Baishao), and *Psoralea corylifolia* (Buguzhi). Its therapeutic mechanism is characterized by tonifying the lung Qi, nourishing the blood, and activating blood circulation to resolve stasis, thereby improving pulmonary function and reducing clinical symptoms like cough and dyspnea. It has also been investigated for its potential role in managing pulmonary fibrosis and supporting recovery from respiratory infections.

Brand names
Bufei Huoxue Capsules
Other names
补肺活血胶囊Bufei Huoxue Jiaonang
02

Targets

IL-6 (Interleukin 6)Transforming growth factor beta 1 / Mothers against decapentaplegic homolog 2/3 signaling axis

Beyond the preview

Go deeper on bufei huoxue capsules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bufei huoxue capsules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call